Docencia
Servizo
Patricia E.
Carreira
Publicacións nas que colabora con Patricia E. Carreira (23)
2022
-
Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis
Immunity and Ageing, Vol. 19, Núm. 1
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2020
-
Toll-like receptor 3 increases antigen-presenting cell responses to a pro-apoptotic stimulus, yet does not contribute to systemic lupus erythematosus genetic susceptibility
Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 881-890
2019
-
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept
PLoS ONE, Vol. 14, Núm. 2
-
Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study
Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360
2018
-
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis
PLoS ONE, Vol. 13, Núm. 5
2017
-
A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294
-
Overexpression of the cytokine BAFF and autoimmunity risk
New England Journal of Medicine, Vol. 376, Núm. 17, pp. 1615-1626
2016
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
2015
-
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors
Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis
Pharmacogenetics and Genomics, Vol. 24, Núm. 5, pp. 238-245
-
Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus
Arthritis Research and Therapy, Vol. 16, Núm. 3
-
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: A genome-wide association study replication and meta-analysis
Arthritis Research and Therapy, Vol. 16, Núm. 2
2012
-
Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: A case-control study
Arthritis Research and Therapy, Vol. 14, Núm. 2
-
Further Evidence of Subphenotype Association with Systemic Lupus Erythematosus Susceptibility Loci: A European Cases Only Study
PLoS ONE, Vol. 7, Núm. 9
2011
2009
-
Replication of recently identified systemic lupus erythematosus genetic associations: A case-control study
Arthritis Research and Therapy, Vol. 11, Núm. 3
2007
-
Opposed independent effects and epistasis in the complex association of IRF5 to SLE
Genes and Immunity, Vol. 8, Núm. 5, pp. 429-438
-
Study of DNASE I gene polymorphisms in systemic lupus erythematosus susceptibility [3]
Annals of the Rheumatic Diseases